These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Chemotherapeutic trials in leprosy. 5. A study of methods used in clinical trials in lepromatous leprosy. Waters MF; Rees RJ; Sutherland I Int J Lepr Other Mycobact Dis; 1967; 35(3):311-35. PubMed ID: 4917107 [No Abstract] [Full Text] [Related]
3. The therapeutic effect of 4,4'-diacetyldiamino-diphenylsulfone (DADDS) in leprosy. Shepard CC; Tolentino JG; McRae DH Am J Trop Med Hyg; 1968 Mar; 17(2):192-201. PubMed ID: 4870563 [No Abstract] [Full Text] [Related]
4. The treatment of leprosy with the sulfones. I. Faget's original 22 patients. A thirty-year follow-up on sulfone therapy for leprosy. Jacobson RR; Trautman JR Int J Lepr Other Mycobact Dis; 1971; 39(3):726-37. PubMed ID: 4948221 [No Abstract] [Full Text] [Related]
5. Comments on the chemotherapy of leprosy as influenced by present knowledge of Mycobacterium leprae. Pattyn SR Lepr Rev; 1973 Sep; 43(3):126-36. PubMed ID: 4120832 [No Abstract] [Full Text] [Related]
6. Drug resistance of Mycobacterium leprae, particularly to DDS. Rees RJ Int J Lepr Other Mycobact Dis; 1967; 35(4):625-38. PubMed ID: 4173566 [No Abstract] [Full Text] [Related]
7. Elimination of leprosy and its consequences for research. Faber WR; Klatser PR Adv Exp Med Biol; 2003; 531():295-7. PubMed ID: 12916801 [No Abstract] [Full Text] [Related]
10. Drug resistance in leprosy. Browne SG Lepr Rev; 1974 Sep; 45(3):276-8. PubMed ID: 4612275 [No Abstract] [Full Text] [Related]
11. The sensitivity to Dapsone (DDS) of Mycobacterium leprae from patients with and without previous treatment. Shepard CC; Levy L; Fasal P Am J Trop Med Hyg; 1969 Mar; 18(2):258-63. PubMed ID: 4888029 [No Abstract] [Full Text] [Related]
12. The treatment of leprosy. Waters MF Tubercle; 1983 Sep; 64(3):221-32. PubMed ID: 6356539 [No Abstract] [Full Text] [Related]
13. Treatment of sulphone resistant leprosy--a review of sixty one cases. Seshadri PS; Ravi NT Lepr India; 1982 Oct; 54(4):639-47. PubMed ID: 6191123 [No Abstract] [Full Text] [Related]
14. Controlled long-term therapy of leprosy with B663 (lamprene, clofazimine) compared with DDS. Tolentino JG; Rodriquez JN; Abalos RM Int J Lepr Other Mycobact Dis; 1974; 42(4):416-418. PubMed ID: 4617720 [No Abstract] [Full Text] [Related]
15. Chemotherapy of leprosy. Shepard CC Annu Rev Pharmacol; 1969; 9():37-50. PubMed ID: 4892433 [No Abstract] [Full Text] [Related]
16. Studies on sulfone resistance in leprosy. 3. A case of "partial" resistance. Pearson JM; Pettit JH; Rees RJ Int J Lepr Other Mycobact Dis; 1968; 36(2):171-8. PubMed ID: 4877115 [No Abstract] [Full Text] [Related]
17. [Importance of repeated immunological stimulation using BCG in the treatment of lepromatous leprosy. New evaluation of 13 patients]. Ruscher H; Faye I; Languillon J; Sarrat H; Oudart JL; Carnus H Bull Soc Med Afr Noire Lang Fr; 1973; 18(4):470-6. PubMed ID: 4599200 [No Abstract] [Full Text] [Related]
18. Studies on dapsone-resistant Mycobacterium leprae in leprosy patients of Gudiyatham Taluk, the leprosy control area of the Schieffelin Leprosy Research and Training Centre, Karigiri. 2. A progress report. Almeida JG; Christian M; Chacko CJ; Taylor PM; Fritschi EP Lepr Rev; 1983 Sep; 54(3):185-91. PubMed ID: 6355722 [No Abstract] [Full Text] [Related]
19. [Chemotherapy of leprosy. I. Sulfones and sulfonamides]. Leiker DL Ned Tijdschr Geneeskd; 1979 Jun; 123(23):969-72. PubMed ID: 460449 [No Abstract] [Full Text] [Related]